FDA lays out what to expect at adcomm's selection of strains for Covid-19 vaccine campaign this fall
The FDA on Monday published its briefing documents ahead of Thursday’s vaccine advisory committee, with the experts readying a recommendation on what Covid-19 strains to use for the upcoming vaccine season, as the agency typically does for every flu season.
The meeting will be crucial for Moderna, Pfizer and BioNTech, and Novavax, all of which have approved or authorized (as in the case of Novavax) Covid-19 vaccines that will be updated this fall.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
